HIGHLIGHTS: Stable BPC-157, a novel anti-ulcer peptide (1) BPC-157: Healing in different tissues Tendon Healing (4) Bone healing BPC-157 & Neuroprotective effect Effect on Spinal Cord Injury Blood Pressure Tendon Healing (4) Bone healing Stable BPC-157 as anti-ulcer agent (1) Stable gastric pentadecapeptide BPC 157 is a novel anti-ulcer peptide, used in trials for the treatment of ulcerative colitis and now multiple sclerosis, lethal dose (dosage required to kill 1% of the test population, LD1) not reported
Semax (BDNF/TrkB pathway, neuroplasticity) and the Selank (GABAergic pathway, anxiolysis) act through non-competitive and complementary mechanisms
study, effects in fast-aging mice were observable within 10-14 days of treatment initiation
[154] See also [edit] Further reading [edit] "Navigating the B(12) road: assimilation, delivery, and disorders of cobalamin"
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands